{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-032680","form_type":"8-K/A","ticker":"SONM","cik":"0001178697","company_name":"DNA X, Inc.","filed_at":"2026-07-09T20:05:15+00:00","discovered_at":"2026-07-09T20:06:00.729601+00:00","generated_at":"2026-07-09T20:06:12.144226+00:00","sec_items":["8.01","3.02","3.03","5.03"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"DNA X raises $2.5M in Series B Preferred, cancels $3.1M debt to meet Nasdaq equity requirement","bullets":["Sold 929,864 Series B Preferred shares for $2.5M cash and cancellation of $3.1M convertible note balance.","Pro forma stockholders' equity as of July 9, 2026 is $3.798M, above Nasdaq's $2.5M minimum.","Remaining 416,667 Series B shares expected to close by August 14, 2026.","Company awaits Nasdaq formal determination of compliance with minimum equity rule."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-032680","json":"https://secwatch.observer/filing/0001493152-26-032680.json","markdown":"https://secwatch.observer/filing/0001493152-26-032680.md","text":"https://secwatch.observer/filing/0001493152-26-032680.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226032680/0001493152-26-032680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226032680/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-09T20:06:12.144226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}